The clinical significance of the multidrug resistance proteins expression in patients with acute myeloid leukemia.

被引：1
|
作者：
Podolak-Dawidziak, M
Dus, D
Kielbinski, M
Paprocka, M
Kuliszkowicz-Janus, M
Kuliczkowski, K
机构：
[1] Med Univ, Dept Haematol, Wroclaw, Low Silesia, Poland
[2] Polish Acad Sci, Inst Immunol & Expt Therapy, Wroclaw, Low Silesia, Poland
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.4411.4411
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4411
引用
收藏
页码：186B / 186B
页数：1
相关论文
共 50 条
  • [21] Prognostic significance of natural killer expression in Egyptian pediatric acute myeloid leukemia.
    Sidhom, I
    Kamel, A
    El-Sharkawy, N
    Yassin, D
    Shaaban, K
    Hussein, H
    Naga, SA
    Moussa, H
    Mosallam, G
    El-Nahass, Y
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 810S - 810S
  • [22] Expression and clinical significance of multidrug resistance proteins in brain tumors
    Guo, Zhenhua
    Zhu, Jin
    Zhao, Lihua
    Luo, Qing
    Jin, Xianqing
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2010, 29
  • [23] Expression and clinical significance of multidrug resistance proteins in brain tumors
    Zhenhua Guo
    Jin Zhu
    Lihua Zhao
    Qing Luo
    Xianqing Jin
    Journal of Experimental & Clinical Cancer Research, 29
  • [24] Clinical significance of CD56 expression in patients with acute myeloid leukemia
    Lee, JJ
    Chung, IJ
    Yang, DH
    Cho, SH
    Cho, D
    Ryang, DW
    Kim, HJ
    LEUKEMIA & LYMPHOMA, 2002, 43 (09) : 1897 - 1899
  • [25] Multidrug resistance gene expression in acute myeloid leukemia: Major prognosis significance for in vivo drug resistance to induction treatment
    Hunault, M
    Zhou, D
    Delmer, A
    Ramond, S
    Viguie, F
    Cadiou, M
    Perrot, JY
    Levy, V
    Rio, B
    Cymbalista, F
    Zittoun, R
    Marie, JP
    ANNALS OF HEMATOLOGY, 1997, 74 (02) : 65 - 71
  • [26] Multidrug resistance gene expression in acute myeloid leukemia: Major prognosis significance for in vivo drug resistance to induction treatment
    M. Hunault
    D. Zhou
    A. Delmer
    S. Ramond
    F. Viguié
    M. Cadiou
    J.-Y. Perrot
    V. Levy
    B. Rio
    F. Cymbalista
    R. Zittoun
    J.-P. Marie
    Annals of Hematology, 1997, 74 : 65 - 71
  • [27] Aberrant expression of angiotensin in acute myeloid leukemia.
    Pinto, RP
    Wang, KK
    Khoury, H
    Schimmer, AD
    Minden, MD
    BLOOD, 2003, 102 (11) : 577A - 577A
  • [28] Aberrant gene expression in acute myeloid leukemia.
    Pinto, RP
    Wang, KK
    Schimmer, AD
    Minden, MD
    BLOOD, 2001, 98 (11) : 93A - 93A
  • [29] MULTIDRUG RESISTANCE IN ACUTE MYELOID-LEUKEMIA
    BAER, MR
    BLOOMFIELD, CD
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (10) : 663 - 665
  • [30] Prognostic significance of risk group stratification in elderly patients with acute myeloid leukemia.
    Wahlin, A
    Markevarn, B
    Golovleva, I
    Nilsson, M
    BLOOD, 2000, 96 (11) : 207B - 207B
12345